TickerSutra

NSE: CYIENT · BSE: 532175 · ISIN INE136B01020

Cyient Limited stock analysis

Cyient Limited ranks #2802 in the TickerSutra evidence-ranked universe with a score of 44/100 and 95% data confidence. The latest captured fundamentals show ROCE of 12.3%, quarterly sales growth of 21.3% and quarterly profit growth of -32.3%.
Complete evidence gate pass governance reviewUpdated 29 Sept 2026
TICKERSUTRA SCORE44/100

Avoid / exit review

#2802 of 5,430 ranked equities
Market capitalisation₹12,048cr
ROCE12.3%
Quarterly sales growth21.3%
Quarterly profit growth-32.3%
P/E ratio29.6×
Promoter pledge0.0%

INVESTMENT EVIDENCE

What supports—and challenges—the thesis

Evidence in favour

  • Low debt/equity of 0.08×
  • Strong CFO/EBITDA of 0.88×
  • CWIP indicates an active capacity pipeline
  • No promoter shares are reported as pledged

Risks and constraints

  • Promoter holding is below 25%

Still unresolved: Related-party exposure · Broad media sentiment

FINANCIAL TRAJECTORY

Recent operating history

PeriodRevenueOperating profitNet profitOperating margin
2022₹4,534cr₹818cr₹522cr18.0%
2023₹6,016cr₹1,003cr₹514cr17.0%
2024₹7,147cr₹1,303cr₹703cr18.0%
2025₹7,360cr₹1,138cr₹648cr15.0%
2026₹7,268cr₹899cr₹463cr12.0%
TTM₹7,632cr₹934cr₹414cr12.0%
Debt / equity0.08×
CFO / EBITDA0.88×
Operating margin12.0%
Free cash flow₹693cr
Sales CAGR · 3Y6.5%
Profit CAGR · 3Y-3.4%

EXCHANGE EVENT TRIGGERS

Latest corporate disclosures

0 positive catalysts0 negative catalysts5 routine filings

MANAGEMENT COMMENTARY

Signals from filed documents

Customer concentrationHigh severity · 1 mention
Risk easing

Better Customer Mining The Group continues to stress improving revenue per customer by focusing on strategic customers and generating more up-sell and cross-sell opportunities. The contribution from the top customers in FY26 has been slightly higher than previous years given the evolving and variable demand cycles and cash spends across Cyient’s key customers at the back of the prevalent macro-economic and geo-politi

Management confidenceHigh severity · 3 mentions
Constructive

While the results in the near term has been challenged, we have rebuilt our go -to-market team in several important geographies and more important we have created a better perspective and understanding of what we need to take to the market and how we need to play in the market. We are confident that this will start showing market comparable results in the next two, three quarters. Other market segments in strategic u

Margin expansionHigh severity · 2 mentions
Positive catalyst

Apart from the market -specific impact I mentioned, we did see some slowness in awarding of discretionary projects as customers across the globe were cautious on starting new programs with some of the uncertainty and supply chain disruptions due to the West Asia war and the situation that has unfolded because of that. Despite this slight drop in revenue, our ongoing focus on operating margin improvements resulted in

Margin pressureModerate severity · 1 mention
Risk easing

Alongside, customers are consolidating their ER&D vendor base in favour of fewer , deeper strategic partners with multi-domain depth and proven AI-engineering capability — driving renewed large-deal momentum. With a strong and balanced portfolio of focus industries and offerings, and a clear commitment to embracing intelligence at the heart of its engineering proposition, Cyient is well-positioned to participate in t

Regulatory updatesModerate severity · 54 mentions
Constructive

Business Ethics, Integrity & T ranspar- ency Risk Engaging in unethical business practices poses significant risks to Cyient’s financial stability and corporate reputation. Such actions can lead to serious legal and regulatory repercussions, including fines, sanctions, and operational conflicts. Beyond the immediate consequences, unethical conduct undermines stakeholder trust - eroding customer loyalty, diminishing m

Regulatory approvalLow severity · 6 mentions
Watch

Whether your entity’s policy/policies cover each principle and its core elements of the NGRBCs. Has the policy been approved by the Board? Whether the entity has translated the policy into procedures.

Institutional interestLow severity · 1 mention
Watch

Opportunity to ask questions to the Board of directors, to place items on the agenda of general meetings, and to propose resolutions, subject to reasonable and statutory limitations e. Exercise of ownership rights by all shareholders, including institutional investors. Adequate mechanism to address the grievances of the shareholders.

HOW TO READ THIS PAGE

Evidence, freshness and limitations

What does the TickerSutra score mean?

The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.

Which sources support this page?

Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.

Why can an item be unresolved?

Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.

Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer

DIRECTOR & BUSINESS NETWORK

Loading corporate intelligence

Loading universe coverage and exchange-backed evidence…